In collaboration with @EisaiUS, we’re proud to announce today’s #FDA approval of a new combination treatment option for certain patients with advanced renal cell carcinoma, marking an important step forward for people living with #KidneyCancer. Learn more: go.merck.com/~nex
Today, we announced Phase 2b/3 topline results for our investigational therapy in patients with #DiabeticMacularEdema (DME). This important milestone reflects our ongoing commitment to advancing research in #ophthalmology.
Learn more: go.merck.com/~k7a
Today, the FDA approved an updated label for a treatment option for adults living with pulmonary arterial hypertension (#PAH).
Read more: go.merck.com/~c9i
